INSTITUTION'S PROFILE
Sanofi, Bridgewater, NJ, USA.
Publications (1)
Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis.
Journal: Arthritis research & therapy
Publication date: 2019
Journal: Arthritis research & therapy
Publication Year: 2019